Cancers 2013, 5(2), 357-371; doi:10.3390/cancers5020357

Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research

1,†,* email, 1,†email, 2,†email, 3email, 1email, 1email, 1email, 4email, 4email, 3email, 3email, 3email, 3email, 3email, 3email, 3email, 5email, 6email, 2email, 2email and 1,7email
Received: 18 February 2013; in revised form: 18 March 2013 / Accepted: 22 March 2013 / Published: 3 April 2013
(This article belongs to the Special Issue Glioblastoma)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Brain cancer research has been hampered by a paucity of viable clinical tissue of sufficient quality and quantity for experimental research. This has driven researchers to rely heavily on long term cultured cells which no longer represent the cancers from which they were derived. Resection of brain tumors, particularly at the interface between normal and tumorigenic tissue, can be carried out using an ultrasonic surgical aspirator (CUSA) that deposits liquid (blood and irrigation fluid) and resected tissue into a sterile bottle for disposal. To determine the utility of CUSA-derived glioma tissue for experimental research, we collected 48 CUSA specimen bottles from glioma patients and analyzed both the solid tissue fragments and dissociated tumor cells suspended in the liquid waste fraction. We investigated if these fractions would be useful for analyzing tumor heterogeneity, using IHC and multi-parameter flow cytometry; we also assessed culture generation and orthotopic xenograft potential. Both cell sources proved to be an abundant, highly viable source of live tumor cells for cytometric analysis, animal studies and in-vitro studies. Our findings demonstrate that CUSA tissue represents an abundant viable source to conduct experimental research and to carry out diagnostic analyses by flow cytometry or other molecular diagnostic procedures.
Keywords: glioblastoma; glioma; brain cancer; CUSA; surgical aspirate; multiplex flow cytometric analysis; brain cancer stem cells; tumor heterogeneity
PDF Full-text Download PDF Full-Text [1300 KB, uploaded 3 April 2013 14:38 CEST]

Export to BibTeX |

MDPI and ACS Style

Day, B.W.; Stringer, B.W.; Wilson, J.; Jeffree, R.L.; Jamieson, P.R.; Ensbey, K.S.; Bruce, Z.C.; Inglis, P.; Allan, S.; Winter, C.; Tollesson, G.; Campbell, S.; Lucas, P.; Findlay, W.; Kadrian, D.; Johnson, D.; Robertson, T.; Johns, T.G.; Bartlett, P.F.; Osborne, G.W.; Boyd, A.W. Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research. Cancers 2013, 5, 357-371.

AMA Style

Day BW, Stringer BW, Wilson J, Jeffree RL, Jamieson PR, Ensbey KS, Bruce ZC, Inglis P, Allan S, Winter C, Tollesson G, Campbell S, Lucas P, Findlay W, Kadrian D, Johnson D, Robertson T, Johns TG, Bartlett PF, Osborne GW, Boyd AW. Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research. Cancers. 2013; 5(2):357-371.

Chicago/Turabian Style

Day, Bryan W.; Stringer, Brett W.; Wilson, John; Jeffree, Rosalind L.; Jamieson, Paul R.; Ensbey, Kathleen S.; Bruce, Zara C.; Inglis, Po; Allan, Suzanne; Winter, Craig; Tollesson, Gert; Campbell, Scott; Lucas, Peter; Findlay, Wendy; Kadrian, David; Johnson, David; Robertson, Thomas; Johns, Terrance G.; Bartlett, Perry F.; Osborne, Geoffrey W.; Boyd, Andrew W. 2013. "Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research." Cancers 5, no. 2: 357-371.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert